STOCK TITAN

WOLTERS KLUWER (WTKWY) Stock News, Feb-Mar 2023

WTKWY OTC

Wolters Kluwer issues news about its global professional information, software, and services business, represented in the U.S. by the WTKWY sponsored Level 1 ADR. Updates commonly cover healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG solutions.

Recurring items include trading updates by business area, annual report and AGM materials, Supervisory Board and executive changes, dividend proposals, portfolio actions, and technology investments. Company announcements also track AI-enabled offerings and platforms such as FAB, Expert AI capabilities in CCH Axcess and UpToDate, legal technology products including Legisway and Kleos, and cloud automation tools such as CodaBox, ClearFacts, Kyte, and Flowin.

Rhea-AI Summary

Wolters Kluwer Health has partnered with Hollywood Presbyterian Medical Center and Sentara Healthcare to implement the Ovid Synthesis Clinical Evidence Manager, enhancing evidence-based clinical research initiatives. This cloud-based tool will support HPMC's Shared Governance Program and Sentara's Nurse Residency Program, streamlining the research process through AI-driven literature review and collaboration. The solution aims to increase project visibility, ensure compliance, and optimize clinical quality amid resource constraints. Launched in 2022, Ovid Synthesis is also being adopted by other institutions like the University of Alabama at Birmingham.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.08%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.08%
Tags
buybacks
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
none
Rhea-AI Summary

Wolters Kluwer Legal and Regulatory U.S. has launched the new Outpatient Prospective Payment System (OPPS) Batch Grouper and Calculator Service within its MediRegs platform. This tool allows healthcare professionals to batch-calculate up to 100,000 outpatient claims daily, significantly improving efficiency in reimbursement and audit processes. It aims to help users address the challenges posed by the evolving reimbursement landscape in the U.S., thereby reducing the time spent on repetitive tasks. The company reported revenues of €5.5 billion in 2022 and serves customers in over 180 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
none
-
Rhea-AI Summary

Wolters Kluwer has released its 2022 Annual Report, detailing financial performance and key metrics for the year. The Annual General Meeting of Shareholders is scheduled for May 10, 2023, where shareholders will vote on financial statements and a proposed dividend of €1.81 per ordinary share, with a final dividend of €1.18 if approved. Total annual revenues for 2022 were €5.5 billion. The report, accessible online, includes proposals for board reappointments and auditor appointments for 2025-2028. Wolters Kluwer serves customers in over 180 countries and employs around 20,000 people worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
management
Rhea-AI Summary

Wolters Kluwer ELM Solutions is hosting the Legal Leaders Exchange Live on March 8 in New York City, focusing on strategies to control legal spend for the finance and insurance sectors. Nathan Cemenska will provide insights on outside counsel rates and spending trends, while Abhishek Mittal will explore AI applications to enhance legal operations. With a strong portfolio that includes top-rated solutions like Passport® and TyMetrix® 360°, the company aims to boost efficiency and streamline processes for legal departments. Wolters Kluwer reported revenues of €5.5 billion in 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.42%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
buybacks
-
Rhea-AI Summary

Wolters Kluwer Health has launched the Coder Workbench, a new high-productivity solution designed to enhance coder efficiency by 20-40% through optimized medical record reviews for risk adjustment workflows. This tool features intuitive workflows, embedded Medicare Advantage intelligence, and intelligent chart organization. Key attributes include a smart chart organization interface, built-in coding assistance, and AI-driven natural language processing to extract clinical indicators. With Medicare Advantage enrollment exceeding 30 million, the tool aims to address compliance and coding accuracy amidst increasing regulatory scrutiny.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
none
Rhea-AI Summary

Wolters Kluwer Health has launched Lippincott® Medical Procedures and Lippincott® Connect Courseware, innovative solutions to enhance medical education. These tools aim to prepare novice clinicians by providing access to trusted educational content and procedural training. The Connect Courseware offers faculty insights into student performance, while students benefit from quizzes and multimedia resources, streamlining their learning experience. The Medical Procedures resource contains evidence-based guidelines for over 60 core medical procedures, ensuring thorough preparation for upcoming professionals. This initiative addresses the growing demand for practice-ready healthcare workers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none

FAQ

What is the current stock price of WOLTERS KLUWER (WTKWY)?

The current stock price of WOLTERS KLUWER (WTKWY) is $77.99 as of October 6, 2026.

What is the market cap of WOLTERS KLUWER (WTKWY)?

The market cap of WOLTERS KLUWER (WTKWY) is approximately 17.3B.